Influence of schedule of administration on methotrexate penetration in brain tumours

European Journal of Cancer

Volumn 36, Issue 12, 2000, Pages 1578-1584

  Dukic, S F ^a   Heurtaux, T ^a   Kaltenbach, M L ^a   Hoizey, G ^a   Lallemand, A ^b   Vistelle, R ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b Laboratoire Pol Bouin   (France)

Author keywords

Glioma; Methotrexate; Microdialysis; Pharmacokinetics; Tissue distribution

Indexed keywords

METHOTREXATE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; DRUG PENETRATION; GLIOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BRAIN NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; INFUSIONS, INTRAVENOUS; MALE; METHOTREXATE; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 0033863258     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00142-8     Document Type: Article

References (23)

1. Pech I.V., Peterson K., Cairncross J.G. Chemotherapy for brain tumors. Oncology. 12:1998;537-553.
2. Zunkeler B., Carson R.E., Olson J.et al. Quantification and pharmacokinetics of blood-brain barrier disruption in humans. J. Neurosurg. 85:1996;1056-1065.
3. Hoang-Xuan K., Delattre J.Y. Chimiothérapie des tumeurs cérébrales malignes primitives de l'adulte. Rev. Prat. 46:1996;450-456.
4. Monjour A., Poisson M., Delattre J.Y. Chimiothérapie des tumeurs cérébrales primitives malignes. La Lettre du Cancérologue. 4:1995;49-67.
5. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science. 161:1968;370-371.
6. Kobayashi N., Allen N., Clendenon N.R., Ko L.W. An improved rat brain-tumor model. J. Neurosurg. 53:1980;808-815.
7. Le Quellec A., Dupin S., Genissel P., Saivin S., Marchand B., Houin G. Microdialysis probes calibration. gradient and tissue dependent changes in no net flux and reverse dialysis methods J. Pharmacol. Toxicol. Meth. 33:1995;11-16.
8. Devineni D., Klein-Szanto A., Gallo J.M. In vivo microdialysis to characterize drug transport in brain tumors. analysis of methotrexate uptake in rat glioma-2 (RG-2)-bearing rats Cancer Chemother. Pharmacol. 38:1996;499-507.
9. Gibaldi M., Perrier D. Pharmacokinetics. 1982;Marcel Dekker, New York.
10. Bernstein J.J., Goldberg W.J., Laws E.R. Jr., Conger D., Morreale V., Wood L.R. C6 glioma cell invasion and migration of rat brain after neural homografting. ultrastructure Neurosurgery. 26:1990;622-628.
11. Menei P, Boisdron-Celle M, Croue A, Guy G, Benoit JP. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 1996, 39, 117-123; discussion 123-124.
12. Morreale V.M., Herman B.H., Der-Minassian V.et al. A brain-tumour model utilizing stereotactic implantation of a permanent cannula. J. Neurosurg. 78:1993;959-965.
13. Chatelut E., Roche H., Plusquellec Y.et al. Pharmacokinetic modeling of plasma and cerebrospinal fluid methotrexate after high-dose intravenous infusion in children. J. Pharm. Sci. 80:1991;730-734.
14. Pignon T., Lacarelle B., Duffaud F.et al. Pharmacokinetics of high-dose methotrexate in adult osteogenic sarcoma. Cancer Chemother. Pharmacol. 33:1994;420-424.
15. Bremnes R.M., Slordal L., Wist E., Aarbakke J. Dose-dependent pharmacokinetics of methotrexate and 7- hydroxymethotrexate in the rat in vivo. Cancer Res. 49:1989;6359-6364.
16. de Lange E.C., de Vries J.D., Zurcher C., Danhof M., de Boer A.G., Breimer D.D. The use of intracerebral microdialysis for the determination of pharmacokinetic profiles of anticancer drugs in tumor-bearing rat brain. Pharm. Res. 12:1995;1924-1931.
17. Dukic S., Heurtaux T., Kaltenbach M.L.et al. Pharmacokinetics of methotrexate in the extracellular fluid of brain C6-glioma after intravenous infusion in rats. Pharm. Res. 16:1999;1219-1225.
18. Hammarlund-Udenaes M., Paalzow L.K., de Lange E.C. Drug equilibration across the blood-brain barrier - pharmacokinetic considerations based on the microdialysis method. Pharm. Res. 14:1997;128-134.
19. Maia M.B., Saivin S., Chatelut E., Malmary M.F., Houin G. In vitro and in vivo protein binding of methotrexate assessed by microdialysis. Int. J. Clin. Pharmacol. Ther. 34:1996;335-341.
20. Paxton J.W. Protein binding of methotrexate in sera from normal human beings. effect of drug concentration, pH, temperature, and storage J. Pharmacol. Meth. 5:1981;203-213.
21. Synold T.W., Relling M.V., Boyett J.M.et al. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J. Clin. Invest. 94:1994;1996-2001.
22. Lokich J., Anderson N. Dose intensity for bolus versus infusion chemotherapy administration. review of the literature for 27 anti-neoplastic agents Ann. Oncol. 8:1997;15-25.
23. Miglioli P.A., Businaro V., Manoni F., Berti T. Tissue distribution of methotrexate in rats. A comparison between intravenous injection as bolus or drip infusion. Drugs Exp. Clin. Res. 11:1985;275-279.